Myriad Genetics Completes Acquisition of Precise Tumor, Prec

SALT LAKE CITY, Feb. 01, 2024 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select...

Related Keywords

Utah , United States , Glenn Farrell , Matt Scalo , Intermountain Health , Nasdaq , Exchange Commission , Genetics Inc , Globenewswire Inc , Intermountain Precision Genomics , Tumor Test , Precise Liquid Test , Precise Tumor Test , Solid Tumor , Precise Tumor , Precise Liquid , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Markets ,